Caffeine mimics the effect of a dopamine D(2/3) receptor agonist on the expression of immediate early genes in globus pallidus

Neuropharmacology

Volumn 36, Issue 9, 1997, Pages 1309-1317

  Svenningsson, Per ^a   Fredholm, Bertil B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adenosine A(2A) receptors; c fos; Caffeine; Globus pallidus; Immediate early genes; In situ hybridization

Indexed keywords

CAFFEINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; GENE EXPRESSION; GLOBUS PALLIDUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030725631     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00091-9     Document Type: Review

References (64)

1. 1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Neuroscience Letters 185: 29-32.
2. Berretta S., Robertson H. A. and Graybiel A. M. (1992) Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. Journal of Neurophysiology 68: 767-777.
3. 2A adenosine receptors on sleep-waking patterns in rats. Drug Development Research 37: 65-72.
4. Cenci M. A., Campbell K., Wictorin K. and Björklund A. (1992) Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. European Journal of Neuroscience 4: 376-380.
5. Curran T., Gordon M. B., Rubino K. L. and Sambucetti L. C. (1987) Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2: 79-84.
6. Daly J. W. (1993) Mechanism of action of caffeine. In: Caffeine, Coffee, and Health (Garattini S, Ed.), pp. 97-150. Raven Press Ltd, New York.
7. 1-receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience 22: 813-826.
8. Ferré S., Fuxe K., von Euler G., Johansson B. and Fredholm B. B. (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51: 501-512.
9. Ferré S., O'Connor W. T., Fuxe K. and Ungerstedt U. (1993) The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. Journal of Neuroscience 13: 5402-5406.
10. 2 dopamine receptors in rat striatum. Molecular Brain Research 14: 186-195.
11. Fredholm B. B. (1980) Are methylxanthine effects due to antagonism of endogenous adenosine? Trends in Pharmacological Sciences 1: 129-132.
12. Fredholm B. B. (1982) Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiologica Scandinavia 115: 283-286.
13. Fredholm B. B. (1995) Adenosine, adenosine receptors and the actions of caffeine. Pharmacology and Toxicology 76: 93-101.
14. 1 receptor number. Brain Research 612: 271-277.
15. Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma Jr F. J. and Sibley D. R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429-1432.
16. Gerfen C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends in Neuroscience 15: 133-139.
17. 3H]-cyclohexyladenosine. Journal of Neuroscience 2: 1230-1241.
18. Graybiel A. M., Aosaki T., Flaherty A. W. and Kimura M. (1994) The basal ganglia and adaptive motor control. Science 265: 1826-1831.
19. Holtzman S. G., Mante S. and Minneman K. P. (1991) Role of adenosine receptors in caffeine tolerance. Journal of Pharmacology and Experimental Therapeutics 256: 62-68.
20. Hughes P. and Dragunow M. (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacological Reviews 47: 133-178.
21. Jaber M., Cador M., Dumartin B., Normand E., Stinus L. and Bloch B. (1995) Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience 65: 1041-1050.
22. Jacobson K. A., Nikodijevic O., Padgett W., Gallo-Rodriguez C., Maillard M. and Daly J. W. (1993) 8-(3-chlorostyryl)-caffeine is a selective A2-adenosine antagonist in vitro and in vivo. FEBS Letters 323: 141-144.
23. Jacobson K. A., von Lubitz D. K. J. E., Daly J. W. and Fredholm B. B. (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends in Pharmacology Sciences 17: 108-113.
24. 3H]CGS 21680. European Journal of Pharmacology 168: 243-246.
25. 2 receptor stimulation on electrically evoked dopamine and acetylcholine release from rat striatal slices. Journal of Pharmacology and Experimental Therapeutics 267: 801-808.
26. 2 adenosine receptor binding and on mRNA levels. Naunyn-Schmiedeberg's Archives of Pharmacology 347: 407-414.
27. Johansson B., Georgiev V., Kuosmanen T. and Fredholm B. B. (1996) Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline-and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding. European Journal of Neuroscience 8: 2447-2458.
28. Keefe K. A. and Gerfen C. R. (1995) D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66: 903-913.
29. Keefe K. A. and Gerfen C. R. (1996) D1 dopamine receptor-mediated induction of zif 268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. Journal of Comparative Neurology 367: 165-176.
30. Lamph W. W., Wamsley P., Sassone-Corsi P. and Verma I. M. (1988) Induction of proto-oncogene jun/AP-1 by serum and TPA. Nature 334: 629-631.
31. Le Moine C., Normand E. and Bloch B. (1991) Phenotypical characterization of the rat striatal neurons expression the D1 dopamine receptor gene. Proceedings of the National Academy of Science of the U.S.A. 88: 4205-1209.
32. Libert F., Schiffmann S. N., Lefort A., Parmentier M., Gérard C., Dumont J. E., Vanderhaeghen J. -J. and Vassart G. (1991) The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO Journal 10: 1677-1682.
33. Linden J., Taylor H. E., Robeva A. S., Tucker A. L., Stehle J. H., Rivkees S. A., Fink J. S. and Reppert S. M. (1993) Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution. Molecular Pharmacology 44: 524-532.
34. Maenhaut C., Van Sande J., Libert F., Abramowicz M., Parmentier M., Vanderhaegen J. J., Dumont J. E., Vassart G. and Schiffmann S. (1990) RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochemical and Biophysical Research Communication 173: 1169-1178.
35. 1 adenosine receptor from rat brain. Molecular Pharmacology 40: 1-7.
36. Marshall J. F., Cole B. N. and LaHoste G. J. (1993) Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres. Brain Research 632: 308-313.
37. Mayfield R. D., Suzuki F. and Zahniser N. R. (1993) Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. Journal of Neurochemistry 60: 2334-2337.
38. 2a/D2 receptor interaction in globus pallidus. Synapse 22: 132-138.
39. Milbrandt J. (1987) A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238: 797-799.
40. Milbrandt J. (1988) Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1: 183-188.
41. Morgan J. I. and Curran T. (1991) Proto-oncogene transcription factors and epilepsy. Trends in Pharmacological Sciences 12: 343-349.
42. Nehlig A., Daval J. L. and Debry G. (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Research and Brain Research Reviews 17: 139-170.
43. 2A receptors. Trends in Pharmacological Sciences 17: 364-372.
44. 3H]-CGS 21680 as a ligand. Naunyn-Schmiedeberg's Archives of Pharmacology 342: 85-89.
45. Paul M. L., Graybiel A. M., David J. -C. and Robertson H. A. (1992) D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Journal of Neuroscience 12: 3729-3742.
46. Paxinos G. and Watson W. (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, London.
47. Rainnie D. G., Grunze H. C. R., McCarley R. W. and Greene R. W. (1994) Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science 263: 689-692.
48. Reppert S. M., Weaver D. R., Stehle J. H. and Rivkees S. A. (1991) Molecular cloning and characterization of a rat Aladenosine receptor that is widely expressed in brain and spinal cord. Molecular Endocrinology 5: 1037-1048.
49. Rivkees S. A., Price S. L. and Zhou F. C. (1995) Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Research 677: 193-203.
50. Robertson L. M., Kerppola T. K., Vendrell M., Luk D., Smeyne R. J., Bocchiaro C., Morgan J. I. and Curran T. (1995) Regulation of c-fos expession in transgenic mice requires multiple interdependent transcription control elements. Neuron 14: 241-252.
51. Ryder K., Lau L. F. and Nathans D. (1988) A gene activated by growth factors is related to the oncogene v-jun. Proceedings of the National Academy of Science of the U.S.A. 85: 1487-1491.
52. 3 adenosine receptor. Biochimica et Biophysica Acta 1179: 105-107.
53. 3 adenosine receptor. Proceedings of the National Academy of Science of the U.S.A. 90: 10365-10369.
54. 2 in rats. Proceedings of the National Academy of Science of the U.S.A. 93: 5980-5984.
55. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. Journal of Neurochemistry 57: 1062-1067.
56. Schiffmann S. N. and Vanderhaeghen J. J. (1993) Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. Journal of Neuroscience 13: 1080-1087.
57. Self D. W. and Nestler E. J. (1995) Molecular mechanisms of drug reinforcement and addiction. Annual Review of Neuroscience 18: 463-495.
58. Snyder S. H., Katims J. J., Annau Z., Bruns R. F. and Daly J. W. (1981) Adenosine receptors and behavioral actions of methylxanthines. Proceedings of the National Academy of Science of the U.S.A. 78: 3260-3264.
59. Stehle J. H., Rivkees S. A., Lee J. J., Weaver D. R., Deeds J. D. and Reppert S. M. (1992) Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Molecular Endocrinology 6: 384-393.
60. Svenningsson P., Nomikos G. G. and Fredholm B. B. (1995) Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. Journal of Neuroscience 15: 7612-7624.
61. 2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of mRNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience, 79: 753-764.
62. 2 agonist effects. Science 238: 719-722.
63. Zerial M., Toschi L., Ryseck R. -P., Schuermann M., Müller R. and Bravo R. (1989) The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO Journal 8: 805-813.
64. Zhou Q. Y., Li C., Olah M. E., Johnson R. A., Stiles G. L. and Civelli O. (1992) Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proceedings of the National Academy of Science of the U.S.A. 89: 7432-7436.